TUMORMARKERSTHYROIDFERTILITYENDOCRINOLOGYDIABETESANEMIAPHOSPHOCALCIC AXISCARDIAC MARKERSHEPATITISOTHERS
 

PRODUCT

REF.
(No of tubes)

METHOD
SEPARATION

TRACER
ACT (kBq)

STANDARD
(No & Range)

CONT.

SAMPLE
(Vol. & type)

INCUBATIONS
(Time/T°)

SHELF-LIFE
(Labelling
periodicity)

COMMENTS

CA 125

ELSA-CA 125 II
(96)

IRMA
ELSA Solid Phase

125 I
481

6
0 → 500U/ml

1

100μl
Serum, Plasma

20 h
RT

7 weeks
(every 2 weeks)

Monoclonal antibodies

ELSA-CA 125 II-SP
(100)

B-TUBE

125 I
481

7
0 → 750U/ml

1

100μl
Serum, Plasma

20 h / RT
(SHAKER)

7 weeks
(every 2 weeks)

Monoclonal antibodies

CA 15-3

ELSA-CA 15-3
(96)

IRMA
ELSA Solid Phase

125 I
555

6
0 → 240U/ml

1

20μl
Serum, Plasma

2 x 1 h
RT

7 weeks
(every 2 weeks)

Monoclonal antibodies

CA 19-9

ELSA-CA 19-9
(96)

IRMA
ELSA Solid Phase

125 I
370

6
0 → 400U/ml

1

100μl
Serum, Plasma

3 h / 37°C
+
3 h / RT

7 weeks
(every 2 weeks)

Monoclonal antibodies
400 U/ml Std in option

ELSA-CA 19-9-SP
(100)

B-TUBE

125 I
370

6
4 → 240U/ml

1

100μl
Serum, Plasma

(2h/RT(SHAKER))*2
or (3h/37°C)*2

7 weeks
(every 2 weeks)

 

CA 72-4

ELSA-CA 72-4
(96)

IRMA
ELSA Solid Phase

125 I
370

5
3 → 100U/ml

1

100μl
Serum, Plasma

4 h / RT
+
18 h / 4°C

7 weeks
(every 2 weeks)

Monoclonal antibodies

CHROMO
-GRANIN A

CGA-RIACT
(100)

IRMA
Coated tubes

125 I
407

5
50 → 1200U/ml

1

50μl
Serum

18 h + 2 h
RT

8 weeks
(every 2 weeks)

Monoclonal antibodies

CYFRA 21-1

ELSA-CYFRA
(48)

IRMA
ELSA Solid Phase

125 I
277

5
0 → 60U/ml

1

100μl
Serum, Plasma

18 h
4°C

7 weeks
(every 2 weeks)

Monoclonal antibodies

AFP

ELSA2-AFP
(96)

IRMA
ELSA Solid Phase

125 I
277.5

7
0 → 800 ng/ml

1

50μl
Serum, Plasma
amniotic fluid

2 x 30'
RT

5 weeks
(every 3 weeks)

Monoclonal antibodies

OCFA07-AFP
(100)

IRMA
Coated tubes

125 I
300

5
0 → 800 UI/ml

2

50μl
Serum, Plasma
amniotic fluid 

2 x 15'
RT

8 weeks
(every 6 weeks)

Monoclonal antibodies

hCG FREE
β subunit

ELSA-FβHCG
(96)

IRMA
ELSA Solid Phase

125 I
555

6
0 → 50ng/ml

1

100μl
Serum, Plasma

1 h + 2 h
RT

5 weeks
(every 4 weeks)

Monoclonal antibodies
Detects only
Free β chains

CALCI
TONIN

ELSA-hCT
(96)

IRMA
ELSA Solid Phase

125 I
555

7
0 → 2250pg/ml

1

200μl
Pretreated serum

20 h
RT

3 weeks
(every 2 weeks)

Monoclonal antibodies

CEA

ELSA2-CEA
(96)

IRMA
ELSA Solid Phase

125 I
296

6
0 → 200ng/ml

1

100μl
Serum, Plasma

3 h
45°C

6 weeks
(every 4 weeks)

Monoclonal antibodies

HTG

ELSA-HTG
(96)

IRMA
ELSA Solid Phase

125 I
222

7
0 → 50ng/ml

1

100μl
Serum, Plasma

3 h + 20 h
RT

6 weeks
(every 4 weeks)

Monoclonal antibodies

NSE

ELSA-NSE
(96)

IRMA
ELSA Solid Phase

125 I
370

6
0 → 200ng/ml

1

50μl
Serum

3 h
RT

6 weeks
(every 4 weeks)

Monoclonal antibodies

PAP

ELSA-PAP
(96)

IRMA
ELSA Solid Phase

125 I
370

6
0 → 50ng/ml

1

100μl
Serum

2 h
RT

4 weeks
(every 4 weeks)

Monoclonal antibodies

PSA

PSA-RIACT
(100)

IRMA
Coated tubes

125 I
370

6
0 → 100ng/ml

1

50μl
Serum, Plasma

2 h
RT

5 weeks
(every 4 weeks)

Monoclonal antibodies
Eqimolar assay

FREE PSA

FPSA-RIACT
(50)

IRMA
Coated tubes

125 I
185

6
0 → 20ng/ml

1

100μl
Serum, Plasma

20 h
RT

5 weeks
(every 4 weeks)

Monoclonal antibodies